Fiorentino, F., B. Canali, P. Morelli, and F. Demma. “Brentuximab Vedotin in Combination With Doxorubicin, Vinblastine and Dacarbazine for First-Line Treatment of Stage IV HL: Cost Impact on Subsequent Lines in Italy”. AboutOpen, vol. 10, no. 1, Jan. 2023, pp. 6-12, doi:10.33393/ao.2023.2486.